Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

Europe - EPA:ALSOG - FR0000065864 - Common Stock

26.4 EUR
-0.5 (-1.86%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

6

ALSOG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 46 industry peers in the Aerospace & Defense industry. ALSOG has an excellent financial health rating, but there are some minor concerns on its profitability. ALSOG scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ALSOG could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALSOG had positive earnings in the past year.
In the past year ALSOG had a positive cash flow from operations.
Of the past 5 years ALSOG 4 years were profitable.
In the past 5 years ALSOG always reported a positive cash flow from operatings.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

With a Return On Assets value of 2.90%, ALSOG perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
With a Return On Equity value of 9.03%, ALSOG perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ALSOG's Return On Invested Capital of 7.14% is in line compared to the rest of the industry. ALSOG outperforms 54.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALSOG is below the industry average of 9.09%.
The last Return On Invested Capital (7.14%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.9%
ROE 9.03%
ROIC 7.14%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With a Profit Margin value of 2.82%, ALSOG perfoms like the industry average, outperforming 41.30% of the companies in the same industry.
ALSOG's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 4.65%, ALSOG is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ALSOG has grown nicely.
With an excellent Gross Margin value of 56.71%, ALSOG belongs to the best of the industry, outperforming 84.78% of the companies in the same industry.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
Industry RankSector Rank
OM 4.65%
PM (TTM) 2.82%
GM 56.71%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALSOG is destroying value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
ALSOG has a better debt/assets ratio than last year.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALSOG has an Altman-Z score of 2.37. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
ALSOG has a Altman-Z score (2.37) which is in line with its industry peers.
ALSOG has a debt to FCF ratio of 1.82. This is a very positive value and a sign of high solvency as it would only need 1.82 years to pay back of all of its debts.
ALSOG has a Debt to FCF ratio of 1.82. This is amongst the best in the industry. ALSOG outperforms 84.78% of its industry peers.
ALSOG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, ALSOG is in the better half of the industry, outperforming 67.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.82
Altman-Z 2.37
ROIC/WACC0.99
WACC7.21%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALSOG has a Current Ratio of 1.69. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.69, ALSOG belongs to the top of the industry, outperforming 80.43% of the companies in the same industry.
ALSOG has a Quick Ratio of 1.44. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG has a Quick ratio of 1.44. This is amongst the best in the industry. ALSOG outperforms 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.44
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.56% over the past year.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.07% in the past year.
ALSOG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.06% yearly.
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%

3.2 Future

Based on estimates for the next years, ALSOG will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.42% on average per year.
ALSOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.01% yearly.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.21, the valuation of ALSOG can be described as rather expensive.
Based on the Price/Earnings ratio, ALSOG is valued cheaper than 97.83% of the companies in the same industry.
ALSOG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
A Price/Forward Earnings ratio of 11.49 indicates a reasonable valuation of ALSOG.
ALSOG's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALSOG is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALSOG to the average of the S&P500 Index (22.77), we can say ALSOG is valued slightly cheaper.
Industry RankSector Rank
PE 18.21
Fwd PE 11.49
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 100.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.52
EV/EBITDA 8.54
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALSOG's earnings are expected to grow with 18.42% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

4

5. Dividend

5.1 Amount

ALSOG has a Yearly Dividend Yield of 3.90%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.16, ALSOG pays a better dividend. On top of this ALSOG pays more dividend than 100.00% of the companies listed in the same industry.
ALSOG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.9%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALSOG pays out 64.84% of its income as dividend. This is not a sustainable payout ratio.
DP64.84%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (9/15/2025, 7:00:00 PM)

26.4

-0.5 (-1.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-10 2025-09-10
Earnings (Next)10-29 2025-10-29
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap84.48M
Analysts86.67
Price Target28.05 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP64.84%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.21
Fwd PE 11.49
P/S 0.54
P/FCF 5.52
P/OCF 4.96
P/B 1.72
P/tB 3.24
EV/EBITDA 8.54
EPS(TTM)1.45
EY5.49%
EPS(NY)2.3
Fwd EY8.7%
FCF(TTM)4.78
FCFY18.1%
OCF(TTM)5.32
OCFY20.17%
SpS49.07
BVpS15.31
TBVpS8.15
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 9.03%
ROCE 8.19%
ROIC 7.14%
ROICexc 9.23%
ROICexgc 13.76%
OM 4.65%
PM (TTM) 2.82%
GM 56.71%
FCFM 9.74%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexcg growth 3Y2.87%
ROICexcg growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.82
Debt/EBITDA 2.03
Cap/Depr 51.95%
Cap/Sales 1.11%
Interest Coverage 7.47
Cash Conversion 160%
Profit Quality 345.65%
Current Ratio 1.69
Quick Ratio 1.44
Altman-Z 2.37
F-Score8
WACC7.21%
ROIC/WACC0.99
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y289.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y203.6%
OCF growth 3Y101.39%
OCF growth 5YN/A